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Background: Primary extracranial meningiomas (PEMs) originating from the nasal septum are extremely rare, as are
extracranial metastases of meningiomas.
Case presentation: A 44-year-old male presented with a 2-month history of left-side nasal obstruction and
frequent episodes of epistaxis. A friable mass originating from the nasal septum was resected completely via an
endoscopic endonasal approach. According to WHO criteria, the tumor was diagnosed as an atypical meningioma
radiologically and histopathologically. Two years later, a tumor recurred at the primary site with the same
histopathological findings, and the patient was given local external radiotherapy (6840 cGy in 38 fractions). Two
months after this local recurrence, a left anterior chest wall mass and a left parietal area scalp mass were observed.
The subcutaneous mass was resected and showed histological evidence of malignant transformation. Several
months after the last operation, the patient died.
Conclusions: We describe the clinical, radiological, and bio-pathological features of this unique case and review the
literature on atypical PEMs originating in the nasal septum. To our knowledge, this is the first reported case of an
atypical PEM originating from the nasal septum that recurred with malignant transformation and extracranial
metastasis.
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MetastasisBackground
Meningiomas are relatively common entities, accounting
for 13–18% of intracranial neoplasms in adults, but they
are rarely seen in extracranial locations, such as the
spine, skull convexities, neck, chest, shoulder, and peri-
toneum [1,2]. Meningiomas in these locations are called
extracranial meningiomas, and they account for fewer
than 2% of all meningiomas [3]. Extracranial meningi-
omas include both primary and secondary types, based
on the absence or presence of intracranial attachments,
respectively. Primary extracranial meningiomas (PEMs,
ectopic meningiomas) arise ectopically within a given tis-
sue with no evidence of direct attachment to the brain* Correspondence: bjbaek@schmc.ac.kr
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reproduction in any medium, provided the ortissue. Of these PEMs, only 11.5% are encountered in
the nasal cavity and paranasal sinuses [4], and one PEM
originating from the nasal septum has been reported [5].
Atypical meningioma is a rare variant that comprises
5-15% of all meningiomas. The reported rate of malig-
nant change in meningiomas is less than 7% [6]. Al-
though metastases may be more frequent in PEMs than
in intracranial meningiomas [7-9], metastatic meningi-
omas are extremely rare (0.1%) [10]. To our knowledge,
this is the first reported case of an atypical PEM originat-
ing from the nasal septum with distant metastasis and
ultimately fatal progression.
Case presentation
A 44-year-old male was admitted to our clinic with a his-
tory of left-side nasal obstruction, episodes of epistaxis,
hyposmia, and postnasal discharge over the previous
2 months. The patient had undergone endoscopic sinusd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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clinic. Otherwise, his medical history was unremarkable.
General and neurological examinations and routine la-
boratory test results were unremarkable. Non-contrast-
enhanced computed tomography (CT) sections revealed
an extensive hypodense non-calcified lesion occupying
the left nasal cavity and pushing against the lateral nasal
wall (Figure 1A). The lesion showed heterogeneous iodi-
nated contrast enhancement and demonstrated remodel-
ing of the adjacent bony structure (Figure 1B). Magnetic
resonance imaging (MRI) showed that the tumor mass
was of slightly lower intensity than the brain parenchyma
on T1-weighted images and heterogeneously isointense
on T2-weighted images, with significant heterogeneous
contrast enhancement on gadolinium administration
(Figure 2A-D). The preoperative CT and MRI showed an
endonasal soft tissue mass with no intracranial connec-
tion. During the operation, a friable mass originating
from the bony-cartilage junction of the nasal septum and
extending to the lateral nasal wall was resected com-
pletely with the attached septal cartilage and nasal mu-
cosa via an endoscopic endonasal approach. The safety
margins were free of disease.
Microscopically, the tumor cells were arranged in
sheet-like growths or were uninterrupted and patternless
and showed nasal septum invasion (Figure 3A). No cellular
whorl, psammoma body, or necrosis was observed.
Individual tumor cells had round-to-oval nuclei, with
prominent nucleoli and dense nuclear membranes. Mitosis
was seen frequently (7/10 HFP, Figure 3B). The immuno-
histochemical profile was positive for epithelial membrane
antigen (Figure 3C) and vimentin (Figure 3D), focal posi-
tive for S-100 protein, and negative for cytokeratin, p63,
and smooth muscle actin. This histopathological investiga-
tion led to a diagnosis of an atypical meningioma (WHO
Grade II) according to WHO criteria [11,12].
Two years later, the patient was readmitted to the
Hematology and Oncology Department of our hospitalFigure 1 Computed tomographic images before surgery. (A) Non-cont
cavity. (B) The lesion showed heterogeneous enhancement on contrast-enhwith recurrent severe epistaxis and general weakness,
which had developed over the previous month. He also
described breathing difficulties. Paranasal sinus CT
showed recurrence of the left nasal cavity tumor, with
palate and maxilla region involvement. Histological in-
vestigation of this second tumor showed morphological
characteristics similar to the primary tumor (Figure 4A).
Positron emission tomography/computed tomography
(PET/CT) was used to identify distant metastases. PET/
CT showed no abnormal glucose metabolic activity, ex-
cept in the nasal cavity and palate region. The patient
received local external radiotherapy (6840 cGy in 38
fractions) for local recurrence of meningioma.
Two months after local recurrence, subcutaneous
tumors were found located on the left anterior chest wall
(1.5 × 1.2 cm) and left parietal region (0.5 × 0.4 cm). The
tumors were removed under local anesthesia. Histo-
logical examination showed morphological characteris-
tics similar to the primary tumor (Figure 4B); however,
the mitotic index (up to 40 mitoses within 10 HPF) and
Ki-67 labeling index (40%) were higher than those of the
primary counterpart. Foci of geographic necrosis were
also found (Figure 4C). The tumor was classified as a
malignant (WHO Grade III) meningioma.
After radiation therapy, the nasal cavity tumor shrank
markedly. However, 2 weeks after the radiation therapy,
multiple small subcutaneous tumors occurred over the
entire body. At that time, the patient was very debilitated
and did not want any other intensive treatment. He was
transferred to a palliative care facility and died 3 months
later.
Conclusions
Primary extracranial meningiomas of the nasal cavity are
extremely rare. To date, about 36 cases have been
reported [5,11,12]. The origin of PEMs is unclear. PEMs
are thought to arise from undifferentiated mesenchymal
stem cells that get trapped or misplaced in intraosseousrast-enhanced PNS CT scan showing the primary lesion in the left nasal
anced CT images.
Figure 2 Magnetic resonance images before surgery. (A) T1-weighted PNS MRI showed a primary lesion of slightly lower signal intensity in
the left nasal cavity. (B) The lesion was heterogeneously isointense on T2-weighted images. (C) Contrast-enhanced MRI showed heterogeneous
enhancement of the lesion. (D) Coronal reconstruction of a T1-weighted MRI scan revealed an isolated primary lesion with no evidence of direct
attachment to brain tissue.
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differentiated arachnoid cap cells associated with blood
vessels or cranial nerves traversing the skull [14].
Atypical meningioma is a rare variant. According to
WHO criteria, meningiomas are classified into three
grades. Most meningiomas are benign (WHO Grade I); 5–
15% of meningiomas are atypical (WHO Grade II); and 1–
2% are anaplastic/malignant (WHO Grade III) [15].
Atypical meningiomas are diagnosed when increased
mitotic activity (defined as ≥4 mitoses/10 HPF) or three
or more of the following features are encountered:
increased cellularity, small cells with a high nucleus:cyto-
plasm ratio, prominent nucleoli, uninterrupted pattern-
less or sheet-like growth, and necrosis [16].
Malignant meningiomas (WHO Grade III) exhibit
histological features of malignancy, including obviously
malignant cytology (e.g., an appearance similar to sar-
coma, carcinoma, or melanoma) and/or a high mitotic
index (≥20 mitoses/10 HPF) [16]. Moreover, malignant
meningiomas are usually fatal and have a higher rate of
recurrence and metastasis [15] than the benign variant.
Perry et al. [17] showed that the median survival time
for malignant meningiomas was 1.5 years, with a 5-year
mortality rate of 68%.The incidence of metastases in meningiomas is very
low. Although surgical removal may increase the risk of
iatrogenic metastases of histologically aggressive men-
ingiomas [18], malignant meningiomas can disseminate
with no previous surgery [19]. The reported incidence of
distant metastases in malignant meningioma is around
43% [20]. The mode of metastatic spread is unclear. Three
possible dissemination patterns have been described:
hematogenous, lymphatic, and via the CSF [20]. In PEMs,
the likely routes of distant metastases are venous and
lymphatic, because PEMs have no intracranial attach-
ments. Metastasis via the venous system usually causes
pulmonary, hepatic, and skeletal metastases, while that via
the lymphatic system causes lymph node and subcutane-
ous metastases [21]. In this case, distant metastases were
seen in the anterior chest wall and scalp 2 months after
local recurrence. However, with time, multiple subcutane-
ous tumors developed over the entire body, so it is pos-
sible that distant metastasis to vital organs, such as the
lungs or liver, occurred.
We presented the case of a middle-aged male with
distant metastasis from a PEM of atypical histology
originating from the nasal septum. Although classified
histologically as atypical, the meningioma exhibited
Figure 3 Histopathology of the primary tumour. (A) Uniform cells with a sheet-like or vague parallel fascicle-like growth involving the nasal
septum (×100, H&E). (B) Atypical cells having round-to-oval nuclei, with prominent nucleoli and occasional mitoses (×400, H&E). The tumour cells
were diffusely positive for EMA (C, ×400) and vimentin (D, ×400).
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malignant meningioma after surgery. Additionally, it is
known that meningiomas tend to become more histolo-
gically aggressive with each recurrence [21]. In our case,
this clinical characteristic was seen.
Currently, complete surgical excision of PEMs is the
treatment of choice and there is no need for adjuvant
treatment [11]. However, our case showed that tumors
invade adjacent septal cartilage, and it has been reported
that adjuvant radiotherapy contributed significantly to
improvements in overall survival and recurrence-free
survival in intracranial meningiomas with local tissueFigure 4 Histopathology of the recurred and metastatic tumours. (A)
frequent mitoses in the nasal cavity recurring tumour. (B) The metastatic tu
Ki-67 labeling index (40%) than the primary tumour (×400, H&E). (C) Geograinvasion [22]. Given their anatomical complexity and the
fact that they are covered with mucosal epithelium,
which has many vascular and lymphatic channels, PEMs
in the nasal cavity have a higher risk of incomplete
tumor resection. Therefore, routine postoperative adju-
vant radiotherapy and careful postoperative imaging may
be necessary to improve the outcome in patients with
atypical PEMs in the nasal cavity.
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